Delivery Order SPE2DB20D1004-SPE2DB25F1673
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,237.94 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $5,755.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $116,508.27. This firm fixed-price delivery order represents a non-set-aside competitive award and is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $15,833.37. This firm fixed-price contract, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,692.22 for Myrbetriq ER 50 mg tablets (90-count supply) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count) with a ceiling value of $5,342.37. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a contract ceiling value of $16,366.65. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The order is due for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,783.17 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for Myrbetriq ER 50 mg tablets (90-count supply). The contract is valued at $22,567.53 with a firm fixed price structure and an ultimate completion date of September 11, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery...